What is
Faropenem?
Faropenem is an orally-active
beta-lactam antibiotic belonging to the penem group.
It is resistant to some forms of extended-spectrum
beta-lactamase.It is orally available.
Clinical use
Faropenem has yet to receive marketing approval in the
United States, and was submitted for consideration by the
United States Food and Drug Administration (FDA) on 20
December 2005. The new drug application (NDA) dossier
submitted included four proposed indications:
-acute bacterial sinusitis
-community acquired pneumonia
-acute exacerbations of chronic bronchitis
-uncomplicated skin and skin structure infections
![Faropenem sodium hemipentahydrate, 6-[(1R)-1-Hydroxyethyl]-7-oxo-3-[(2R)-tetrahydro-2-furanyl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid monosodium salt hemipentahydrate, CAS #: 106560-14-9](../API-A-E/106560-14-9.gif)